Low molecular weight serine proteinase inhibitors of human articular cartilage. Isolation, Characterization, and Biosynthesis

Arthritis & Rheumatism

Volumn 33, Issue 9, 1990, Pages 1384-1393

  Andrews, John L ^a,b   Ghosh, Peter ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PROTEINASE; RADIOISOTOPE;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL;

AMINO ACIDS; CARTILAGE, ARTICULAR; ENZYME INHIBITORS; HUMAN; MOLECULAR WEIGHT; SERINE PROTEINASE INHIBITORS;

EID: 0024996979     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780330911     Document Type: Article

References (54)

1. Synthesis of collagenase and neutral proteases by articular chondrocytes: stimulation by a macrophage‐derived factor.
2. Induction of the synthesis of latent collagenase and latent neutral protease in chondrocytes by a factor synthesized by activated macrophages.
3. Factors involved in cartilage injury.
4. Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.
5. Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues.
6. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (interleukin 1).
7. Mononuclear cell factors stimulate the concomitant secretion of distinct latent proteoglycan, gelatin and collagen degrading enzymes from human skin fibroblasts and synovial cells.
8. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular‐cartilage: escape from inactivation by alpha‐1‐proteinase inhibitor.
9. Osteoarthritis:? an arthritis?
10. Inflammatory synovitis in degenerative joint disease.
11. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis.
12. Two latent metalloproteases of human articular cartilage that digest proteoglycan.
13. Human articular cartilage secretes characteristic metal dependent proteinases upon stimulation by mononuclear cell factor.
14. The action of human articular cartilage metalloproteinase on proteoglycan and link protein: similarities between products of degradation in situ and in vitro.
15. The properties of the neutral proteinase released by primary chondrocyte cultures and its action on proteoglycan aggregate.
16. Characterization of latent and active forms of cartilage proteinases produced by normal immature rabbit articular cartilage in tissue culture.
17. Activation of latent collagenase from polymorphonuclear leukocytes by cathepsin G.
18. Macrophage factor that induces neutral protease secretion by normal rabbit chondrocytes: studies of some properties and effects on metabolism of chondrocytes.
19. Neutral proteinases from articular chondrocytes in culture. 2. Metal‐dependent latent neutral proteoglycanase and inhibitory activity.
20. Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.
21. Serine proteinase activation of latent human skin collagenase.
22. Activation of human neutrophil gelatinase by endogenous serine proteinases.
23. The role of serine protease inhibitors in normal and osteoarthritis human articular cartilage.
24. Synovial membrane‐cartilage interactions: the role of serine proteinase inhibitors in interleukin‐1 mediated degradation of articular cartilage.
25. Collagenase inhibition by cationic proteins derived from cartilage and aorta.
26. Neutral protease inhibitors from human intervertebral disc and femoral head articular cartilage.
27. Proteinase inhibitors of human articular cartilage.
28. Polypeptide proteinase inhibitor from human articular cartilage.
29. Purification and characterization of a serine proteinase inhibitor from human articular cartilage.
30. Variations with aging and degeneration of the serine and cysteine proteinase inhibitors of human articular cartilage.
31. Lysozyme. of cartilage and other connective tissues (a speculative review)
32. Measurement of protein using bicinchoninic acid.
33. A simple and ultrasensitive enzymatic assay for quantitative determination of lysozyme in the picogram range.
34. Simplified silver protein detection and image enhancement methods in polyacrylamide gels.
35. Human leukocyte granule elastase: rapid isolation and characterization.
36. The interaction of pentosan polysulphate (SP54) with human neutrophil elastase and connective tissue matrix components.
37. The action of trypsin on synthetic chromogenic arginine substrates.
38. Cleavage of peptide‐4‐nitroanilide substrates with varying chain length by human leukocyte elastase.
39. A sensitive new substrate for chymotrypsin(1).
40. Neutral proteinases of the human intervertebral disc.
41. Thiobenzyl benzyloxycarbonyl‐L‐lysinate, substrate for a sensitive colorimetric assay for trypsin‐link enzymes.
42. Determination of trypsin and chymotrypsin with remazol brilliant blue‐hide.
43. Pancreatic trypsin inhibition. 2. Reaction with trypsin.
44. The kinetics of reversible tight‐binding inhibition.
45. Titration of trypsin, plasmin and thrombin with p‐nitrophenyl p′‐guanidinobenzoate HCl.
46. Trypsin‐pancreatic trypsin inhibitor association: dynamics of the interaction and role of disulfide bridges.
47. The interaction between alpha‐chymotrypsin and pancreatic trypsin inhibitor (Kunitz inhibitor): kinetic and thermodynamic properties.
48. The inhibition of human leukocyte elastase by basic pancreatic trypsin inhibitor.
49. Detection of proteinase inhibitors using substrate containing sodium dodecyl sulfate‐polyacrylamide gel electrophoresis.
50. Observations on a bacteriolytic substance (“lysozyme”) found in secretions and tissues.
51. Lysozym. as a component of human cartilage
52. Recent developments in the study of lysozymes.
53. Low molecular mass trypsin inhibitors in normal and osteoarthritis human articular cartilage.